PT - JOURNAL ARTICLE AU - Ozery-Flato, Michal AU - Pinchasov, Ora AU - Dabush-Kasa, Miel AU - Hexter, Efrat AU - Chodick, Gabriel AU - Guindy, Michal AU - Rosen-Zvi, Michal TI - Predictive and Causal Analysis of No-Shows for Medical Exams During COVID-19: A Case Study of Breast Imaging in a Nationwide Israeli Health Organization AID - 10.1101/2021.03.12.21253358 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.12.21253358 4099 - http://medrxiv.org/content/early/2021/09/02/2021.03.12.21253358.short 4100 - http://medrxiv.org/content/early/2021/09/02/2021.03.12.21253358.full AB - “No-shows”, defined as missed appointments or late cancellations, is a central problem in healthcare systems. It has appeared to intensify during the COVID-19 pandemic and the nonpharmaceutical interventions, such as closures, taken to slow its spread. No-shows interfere with patients’ continuous care, lead to inefficient utilization of medical resources, and increase healthcare costs. We present a comprehensive analysis of no-shows for breast imaging appointments made during 2020 in a large medical network in Israel. We applied advanced machine learning methods to provide insights into novel and known predictors. Additionally, we employed causal inference methodology to infer the effect of closures on no-shows, after accounting for confounding biases, and demonstrate the superiority of adversarial balancing over inverse probability weighting in correcting these biases. Our results imply that a patient’s perceived risk of cancer and the COVID-19 time-based factors are major predictors. Further, we reveal that closures impact patients over 60, but not patients undergoing advanced diagnostic examinations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research was supported by a grant from the Israel National Institute for Health Policy Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This retrospective study was approved by the institutional review board of Assuta Medical Center (0033-20-ASMC), who waived the requirement for patient consentAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe retrospective data was extracted from the EHR datamart of Assuta Medical Centers and cannot be shared. The other datasets that were analysed in this study are public and their links appear in the manuscript. https://www.google.com/covid19/mobility/ https://www.cbs.gov.il/en/mediarelease/Pages/2020/Characterization-Classification-Geographical%20Unitsby-%20Socio-Economic-Level-Population%202017.aspx https://data.gov.il/dataset/828 https://data.gov.il/dataset/covid-19